William H Cooke1, Keith G Lurie, Mary Jo Rohrer, Victor A Convertino. 1. Department of Health and Kinesiology, University of Texas at San Antonio (W.H.C.), San Antonio, Texas, and Department of Emergency Medicine, Minneapolis Medical Research Foundation and Hennepin County Medical Center, Minneapolis, Minnesota, USA.
Abstract
BACKGROUND: We evaluated the influence of breathing through an inspiratory Impedance Threshold Device (ITD) on autonomic neural and cerebrovascular function. METHODS: Eight subjects breathed through a sham ITD (0 cmH2O) and an active ITD (-7 cmH2O) in the supine position. We recorded the ECG, finger photoplethysmographic arterial pressure, cerebral blood flow velocity, and muscle sympathetic nerve activity (MSNA). In a randomized, counterbalanced design, subjects breathed spontaneously and also breathed at a set cadence of 15 breaths/min (0.25 Hz) for 3 minutes each. Data were analyzed in both time and frequency domains. RESULTS: Breathing through the active ITD increased mean arterial pressure by approximately 5 mm Hg, heart rate by 2 bpm, and mean cerebral blood flow velocity by 10% (p<0.05) with no effect on MSNA or estimates of vagal-cardiac control (p>0.05). The active ITD did not affect oscillations of interbeat R-R intervals, arterial pressures, or cerebral flow velocities within the low frequency (LF) domain of the power spectrum (p>0.05). Cross spectral analysis revealed no effect of the active ITD on transfer function magnitudes among arterial pressures and R-R intervals, or between arterial pressures and cerebral blood flow velocities at the LF (p>0.05). CONCLUSIONS: Our results demonstrate that the ITD increases arterial pressure, heart rate, and cerebral blood flow velocity independent of changes in autonomic cardiovascular control or dynamic cerebral autoregulation. Use of an active ITD in situations of acute central hypovolemia, such as during hemorrhage, may slow the progression to hemodynamic instability in bleeding patients who retain the ability to ventilate spontaneously and robustly.
RCT Entities:
BACKGROUND: We evaluated the influence of breathing through an inspiratory Impedance Threshold Device (ITD) on autonomic neural and cerebrovascular function. METHODS: Eight subjects breathed through a sham ITD (0 cmH2O) and an active ITD (-7 cmH2O) in the supine position. We recorded the ECG, finger photoplethysmographic arterial pressure, cerebral blood flow velocity, and muscle sympathetic nerve activity (MSNA). In a randomized, counterbalanced design, subjects breathed spontaneously and also breathed at a set cadence of 15 breaths/min (0.25 Hz) for 3 minutes each. Data were analyzed in both time and frequency domains. RESULTS: Breathing through the active ITD increased mean arterial pressure by approximately 5 mm Hg, heart rate by 2 bpm, and mean cerebral blood flow velocity by 10% (p<0.05) with no effect on MSNA or estimates of vagal-cardiac control (p>0.05). The active ITD did not affect oscillations of interbeat R-R intervals, arterial pressures, or cerebral flow velocities within the low frequency (LF) domain of the power spectrum (p>0.05). Cross spectral analysis revealed no effect of the active ITD on transfer function magnitudes among arterial pressures and R-R intervals, or between arterial pressures and cerebral blood flow velocities at the LF (p>0.05). CONCLUSIONS: Our results demonstrate that the ITD increases arterial pressure, heart rate, and cerebral blood flow velocity independent of changes in autonomic cardiovascular control or dynamic cerebral autoregulation. Use of an active ITD in situations of acute central hypovolemia, such as during hemorrhage, may slow the progression to hemodynamic instability in bleedingpatients who retain the ability to ventilate spontaneously and robustly.
Authors: Victor A Convertino; Duane A Ratliff; Jacqueline Crissey; Donald F Doerr; Ahamed H Idris; Keith G Lurie Journal: Eur J Appl Physiol Date: 2005-04-28 Impact factor: 3.078
Authors: Christopher G Favilla; Rodrigo M Forti; Ahmad Zamzam; John A Detre; Michael T Mullen; Arjun G Yodh; Scott E Kasner; David R Busch; Wesley B Baker; Rickson C Mesquita; David Kung; Steven R Messé Journal: Neurotherapeutics Date: 2019-10 Impact factor: 6.088
Authors: Christopher G Favilla; Ashwin B Parthasarathy; John A Detre; Arjun G Yodh; Michael T Mullen; Scott E Kasner; Kimberly Gannon; Steven R Messé Journal: Front Neurol Date: 2017-02-16 Impact factor: 4.003
Authors: Anja Hayen; Mari Herigstad; Michael Kelly; Thomas W Okell; Kevin Murphy; Richard G Wise; Kyle T S Pattinson Journal: Neuroimage Date: 2012-10-27 Impact factor: 6.556